4WAG | Phosphatidylinositol 4-kinase III beta crystallized with MI103 inhibitor | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Chalupska, D., Boura, E. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 3.41 | ||||||||||||
ligand | 3K7 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Highly Selective Phosphatidylinositol 4-Kinase IIIbeta Inhibitors and Structural Insight into Their Mode of Action., Mejdrova I, Chalupska D, Kogler M, Sala M, Plackova P, Baumlova A, Hrebabecky H, Prochazkova E, Dejmek M, Guillon R, Strunin D, Weber J, Lee G, Birkus G, Mertlikova-Kaiserova H, Boura E, Nencka R, J Med Chem. 2015 May 14;58(9):3767-93. doi: 10.1021/acs.jmedchem.5b00499. Epub, 2015 May 4. PMID:25897704 |
Data retrieval |
View 4WAG in 3D |
Visual 3D analysis of 4WAG |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4WAG |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |